Multiple methods within a single trial [Regulatives / Guidelines]

posted by wienui  – Germany, Oman, 2019-03-13 18:44 (767 d 03:03 ago) – Posting: # 20027
Views: 3,385

Dear Ohlbe,

» I would reverse the question: why would you use two different methods, or two different technologies, within a single BE trial, with the risk of increasing variability? We're not talking of 2 different trials here (where one can be done at one CRO and the other at another CRO, with a different method).

Please think about very big clinical trials which required a multi-centers ( e.g for Anti-cancer drugs), you deal here with different CRO's which could have different technologies.

Best regards,


Complete thread:

 Admin contact
21,419 posts in 4,475 threads, 1,508 registered users;
online 19 (0 registered, 19 guests [including 3 identified bots]).
Forum time: Sunday 22:48 CEST (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz